Regulatory Effect and Mechanism of Konjac Mannan Oligosaccharides on Atherosclerosis in ApoE- / - Mice

被引：1
|
作者：
Li J. [1 ]
Zhen H. [2 ]
Li Y. [3 ]
Wang N. [1 ]
Yang S. [1 ]
Jiang Z. [1 ]
机构：
[1] College of Food Science and Nutritional Engineering, Key Laboratory of Food Bioengineering (China National Light Industry), China Agricultural University, Beijing
[2] School of Food and Health, Beijing Technology and Business University, Beijing
[3] College of Engineering, China Agricultural University, Beijing
来源：
Journal of Food Science and Technology (China) | 2023年 / 41卷 / 03期
关键词：
atherosclerosis; cholesterol metabolism; gut microbiota; inflammatory factors; konjac mannan oligosaccharides;
D O I：
10.12301/spxb202200591
中图分类号：
学科分类号：
摘要：
Konjac mannan oligosaccharides (KMOS) have a variety of beneficial effects on human health, but their regulator effects on atherosclerosis (AS) and the involved molecular mechanisms have not been well understood. In this study, AS model was established by feeding ApoE - / - mice with high fat diet (HFD) for 14 weeks and used for investigating the effects of KMOS intervention on aortic lipid accumulation, serum lipid, and inflammatory factors. The regulatory effect of KMOS on gut microbiota of AS mice was analyzed by using Illumina high-throughput sequencing technology. The results showed that KMOS supplementation significantly inhibited the increase of body and liver weight induced by HFD. Comparing with HFD group, the area ratio and total area of plaque lesions in aortic sinus induced by HFD was reduced by 57. 4% and 57. 9%, respectively after KMOS treatment. The total serum cholesterol levels and low-density lipoprotein cholesterol levels were decreased by 21. 1% and 31. 1%, whereas the high-density lipoprotein cholesterol level was significantly increased by 63. 0% after KMOS treatment. Meanwhile, lipid accumulation in the liver of HFD induced ApoE - / - mice was significantly improved. The levels serum inflammatory factors (tumor necrosis factor 琢, interleukin-6, interleukin-1β, and monocyte chemotactic protein-1) were reduced by KMOS, compared with AS model group. Moreover, the expression of genes associated with liver cholesterol reverse transport was significantly increased by KMOS. Furthermore, KMOS inhibited the dysbiosis of gut microbiota in ApoE - / - mice induced by HFD with increased relative abundances of g _ norank _ f _ Lachnospiraceae, g _ Alistipes, and g _ norank _ f _ Ruminococcaceae. The production of short chain fatty acids in the cecum was promoted and the expression of intestinal tight junction proteins was increased by KMOS to prevent the impairment of intestinal barrier function. Thus, KMOS could alleviate the development of AS in ApoE - / - mice induced by HFD through the regulation of cholesterol metabolism and gut microbiota. This results aimed to provide theoretical basis for development of KMOS related functional food. © 2023 Beijing Technology and Business University, Department of Science and Technology. All rights reserved.
引用
收藏
页码：41 / 53
页数：12
相关论文
共 37 条
  • [1] Annual report on cardiovascular health and diseases in China (2021), (2022)
  • [2] BAIGENT C, BLACKWELL L, EMBERSON J, Et al., Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, pp. 1670-1681, (2010)
  • [3] CHANG T, STREJA E, MORADI H., Could high-density lipoprotein cholesterol predict increased cardiovascular risk ? [J], Current Opinion in Endocrinology, Diabetes and Obesity, 24, pp. 140-147, (2017)
  • [4] LIBBY P, BURING J, BADIMON L, Et al., Atherosclerosis [J], Nature Reviews Disease Primers, 5, (2019)
  • [5] GISTER魡 A, HANSSON G., The immunology of atherosclerosis [ J], Nature Reviews Nephrology, 13, pp. 368-380, (2017)
  • [6] MARQUES L, DINIZ T, ANTUNES B, Et al., Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol [J], Frontiers in Physiology, 9, (2018)
  • [7] ASCHER S, REINHARDT C., The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease [J], European Journal of Immunology, 48, pp. 564-575, (2018)
  • [8] BATTSON M, LEE D, WEIR T, Et al., The gut microbiota as a novel regulator of cardiovascular function and disease [ J], Journal of Nutritional Biochemistry, 56, pp. 1-15, (2018)
  • [9] FATKHULLINA A, PESHKOVA I, KOLTSOVA E., The role of cytokines in the development of atherosclerosis [J], Biochemistry, 81, pp. 1358-1370, (2016)
  • [10] FATKHULLINA A, PESHKOVA I, DZUTSEV A, Et al., An interleukin-23-interleukin-22 axis regulates intestinal microbial homeostasis to protect from diet-induced atherosclerosis [J], Immunity, 49, (2018)
1234